-
WEBINAR: Integrating Addiction and HIV Prevention and Treatment for Everyone and Bringing It to Where They Live – NIDA HIV Seminar (Jan 24, 1pm ET)
Join the NIDA HIV Research Program for the upcoming NIDA HIV Seminar with Sandra Springer, M.D., of Yale School of Medicine, 2022 recipient of the NIDA HIV Avant-Garde Award. Dr. Springer will present on “Integrating Addiction and HIV Prevention and Treatment for Everyone and Bringing it to Where They Live.” Dr. Springer is a Professor of Medicine at the Yale School of Medicine. Her research integrates aspects of substance use and infectious disease, with a focus on opioid use disorder treatment and the treatment and prevention of HIV among people with carceral experience. Learn more and register here!
-
News from the Western States Node: Deadline to Apply for the LEAD Program is November 30!
The Learning for Early Careers in Addiction and Diversity (LEAD) program, a NIDA-funded science education program focused on addictions research training, is recruiting assistant professors and assistant research scientists for the Learning for Early Careers in Addiction and Diversity (LEAD) Program for the 2024-2025. The LEAD Program provides training to early-career research scientists from racial/ethnic minoritized groups that are underrepresented in the substance use and substance use disorder research field. Contact Michael Shopshire, Ph.D., michael.shopshire@ucsf.edu, if you have any questions about the program or your application. The deadline to submit for the 2024-2025 cohort is November 30, 2023! Find the application here. Posted 11/15/2023
-
NIDA Funding Opportunities
RFA-DA-24-036: The Rural Community-Centered Drug Misuse Prevention and Harm Reduction Research: Addressing Implementation, Dissemination, and Equity Challenges across the Continuum of Care (R61/R33 Clinical Trial Only) This notice of funding opportunity (NOFO) will support research projects that develop and test drug misuse prevention and/or harm reduction strategies, extending the continuum of care within U.S. rural communities impacted by the opioid/stimulant epidemic. The overall goal is to reduce drug use and associated risks and harms for individuals with unmet prevention and/or harm reduction needs. Research activities will be conducted in two phases (i.e., developmental R61 phase and implementation and effectiveness trial R33 phase). Each phase of the project must involve community partners…
-
News from the Northeast Node
The Northeast Node and its parent organization, the Center for Technology and Behavioral Health at Geisel School of Medicine at Dartmouth College, are pleased to welcome Lynn Fiellin, MD, as a Node Core Investigator and faculty professor of Biomedical Data Science, Medicine, and the Dartmouth Institute for Health Policy and Clinical Practice. Dr. Fiellin joins us from the Child Study Center and the School of Public Health at Yale. She is the founding director of the play2PREVENT Lab and of Playbl, Inc. Specifically, her work focuses on developing and testing novel videogame interventions to promote health and reduce risk in youth and young adults. She has received funding from the…
-
New in the CTN Library: October-November 2023
Here are the latest items added to the CTN Dissemination Library for October-November 2023 (this post will be updated as new items come in): Prescription Opioid Dose Reductions and Potential Adverse Events: A Multi-Site Observational Cohort Study in Diverse US Health Systems. Metz VE, et al. Journal of General Internal Medicine 2023 (in press). CTN-0084 Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial. Wartko PD, et al. JAMA Internal Medicine 2023:3235701 (in press). CTN-0074 Assessment of Screening Tools to Identify Substance Use Disorders Among Adolescents. Levy S, et al. JAMA Network Open 2023;6(5):e2314422. Research Priorities for Expansion of Opioid Use Disorder Treatment in the…
-
Submit CPDD Poster Abstracts to the Publications Committee by Dec 1, 2023
CPDD is currently accepting poster abstracts for its June 2024 annual conference, with a deadline of December 29, 2023. CPDD poster abstracts require PC review and approval prior to CPDD submission. PC reviews these poster submissions quickly usually within two weeks. Many reviewers are out of the office the holiday week of Monday, December 25 – Friday, December 29. Please send your poster abstracts for PC review by December 1 to provide adequate time for PC review. Posters should be submitted to Jack Blaine (jblaine@nida.nih.gov) and Susan Sonne (sonnesc@musc.edu). Find out more about CPDD submissions and deadlines here. Posted 11/9/2023
-
News from the Greater Southern California Node
Telehealth & Telemedicine SIG Updates TH/TM SIG November 17th @ 8:30am PT/11:30am ET (see flyer for details) Cynthia Campbell, PhD., and Vanessa Palzes, MPH., will present findings from their study that examined changes in addiction treatment utilization during the first 10 months of the COVID-19 pandemic among adults with drug use problems in the Kaiser Permanente Northern California healthcare system, with a focus on differences by age group, race/ethnicity, and SES. More information about the Telehealth & Telemedicine SIG can be found on the CTN Dissemination Library’s website here. Opioid Use in Rural Communities: A 4-part Series Addressing Implementation and Sustainability of Medication Treatment for Opioid Use Disorder in Clinical Settings…
-
News from the Appalachian Node
Photo slideshow (hover over image and click arrows to move through the set): Posted 11/7/2023
-
News from the New York Node
Sarah Meyers-Ohki recently celebrated 10 years with the New York Node. In November 2013, Sarah joined the department of psychiatry at the New York University Grossman School of Medicine as a Research Coordinator on the CTN-0051 team at Bellevue Hospital. She is now a Senior Project Manager on CTN-0100 – as part of the lead team and managing the Bellevue site. Happy 10th Anniversary, Sarah! Posted 11/7/2023
